If you need more lookups,
subscriptions start at $34 USD/month.
Samuel Wallis Location
London, England, GB
Samuel Wallis Work
Head of Case Managment, Patient Safety @ (March 2022 - Present)
Senior Director, Global Head of ICSR Management Pharmacovigilance deputy QPPV @ (March 2020 - March 2022)
Senior Director, GDSRM International Case Management Operations and Deputy QPPV @ (April 2019 - March 2020)
Director, GDSRM International Case Management Operations and Deputy QPPV @ (March 2017 - April 2019)
Interim Head of Celgene Ltd Drug Safety and Risk Management @ (January 2018 - September 2018)
Associate Director, Pharmacovigilance Operations and Deputy QPPV @ (March 2015 - March 2017)
Manager, Global Drug Safety and Risk Management, Safety Operations @ (April 2013 - April 2014)
Associate Manager, Global Drug Safety and Risk Management, Safety Operations @ (June 2011 - May 2013)
Senior Specialist, Safety Operations @ (August 2009 - June 2011)
EU Pharamcovigilance Associate @ Wyeth Europa Ltd (January 2008 - August 2009)
Samuel Wallis Education
Newcastle University
BSc (Hons) (Pharmacology)
2001-2004
Samuel Wallis Skills
Pharmaceutical Industry
Clinical Trials
Oncology
GCP
Pharmacovigilance
Sop
ICH-GCP
Regulatory Submissions
Regulatory Affairs
Biotechnology
FDA
EDC
Drug Development
Validation
Therapeutic Areas
Regulatory Requirements
Drug Safety
Electronic Data Capture (EDC)
Change Management
Customer Service
Electronic Data Capture Edc
Safety Management Systems
Management
Ich Gcp
Electronic Data Capture
Samuel Wallis Summary
Samuel Wallis, based in London, England, GB, is currently a Head of Case Managment, Patient Safety at Bristol Myers Squibb. Samuel Wallis brings experience from previous roles at Celgene. Samuel Wallis holds a 2001 - 2004 BSc (Hons) in Pharmacology @ Newcastle University. With a robust skill set that includes Pharmaceutical Industry, Clinical Trials, Oncology, GCP, Pharmacovigilance and more. Samuel Wallis has 3 emails on RocketReach.
Looking for a different Samuel Wallis?
Find contact details for 700 million professionals.